Androgen up-regulated VEGF in CWR22 human prostate cancer model

被引：0
|
作者：
Zhang, S [1 ]
Dominguez, J [1 ]
Eble, JN [1 ]
Cheng, L [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
来源：
LABORATORY INVESTIGATION | 2002年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
788
引用
收藏
页码：188A / 189A
页数：2
相关论文
共 50 条
  • [21] Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: Association with tumor cell proliferation prior to recurrence
    Huss, WJ
    Gregory, CW
    Smith, GJ
    PROSTATE, 2004, 60 (02): : 91 - 97
  • [22] Cancer frailty and cachexia induced by prostate cancer cells lines CWR22 and PC-3M
    Andresen, C
    Wang, X
    Salatto, C
    Kowsz, K
    Pero, R
    Lariviere, R
    Bagi, CM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1581 - 1582
  • [23] Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
    Sirotnak, FM
    She, YH
    Lee, F
    Chen, J
    Scher, HI
    CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3870 - 3876
  • [24] Mechanisms of bone formation by prostate cancer cell lines CWR22 and PC-3M
    Bagi, CM
    Hanson, N
    Lariviere, R
    Pero, R
    Kowsz, K
    Gallagher, D
    Andresen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1573 - 1573
  • [25] In vivo preservation of steroid specif icity in CWR22 xenografts having a mutated androgen receptor
    Shao, TC
    Li, HL
    Eid, W
    Ittmann, M
    Unni, E
    Cunningham, GR
    PROSTATE, 2003, 57 (01): : 1 - 7
  • [26] ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines
    Chen, Honglin
    Libertini, Stephen J.
    Wang, Yu
    Kung, Hsing-Jien
    Ghosh, Paramita
    Mudryj, Maria
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (04) : 2368 - 2374
  • [27] Radiation treatment monitoring with DCE-US in CWR22 prostate tumor xenografts
    Arteaga-Marrero, Natalia
    Mainou-Gomez, Jose F.
    Rygh, Cecilie Brekke
    Lutay, Nataliya
    Roehrich, Dieter
    Reed, Rolf K.
    Olsen, Dag R.
    ACTA RADIOLOGICA, 2019, 60 (06) : 788 - 797
  • [28] Protein C inhibitor (plasminogen activator inhibitor-3) expression in the CWR22 prostate cancer xenograft
    Glasscock, LN
    Réhault, SM
    Gregory, CW
    Cooper, ST
    Jackson, TP
    Hoffman, M
    Church, FC
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2005, 79 (01) : 23 - 32
  • [29] The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
    Eisermann, Kurtis
    Fraizer, Gail
    CANCERS, 2017, 9 (04):
  • [30] Studies with CWR22 xenograft models in nude mice suggest that ZD1839 (Iressa) may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer.
    Sirotnak, FM
    She, Y
    Lee, F
    Scher, HI
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3762S - 3763S
12345